Form 4 for DFTX Definium Therapeutics, Inc.
Accepted 2024-08-26 00:00:00 ET · period of report 2024-08-23 · accession 0000950170-24-100668 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-26 | 2024-08-23 | DFTX | GRYSKA DAVID W | Dir | P - Purchase | $5.98 | +3,500 | 17.4K | +25% | +$20.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-08-23 | P | A | 3,500 | $5.98 | 17,351 | D | — | — |